Page last updated: 2024-12-06

2-bromoethanesulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Bromoethanesulfonic acid (BES) is a strong organic acid widely used in organic synthesis and electrochemistry. It is typically synthesized by reacting 2-bromoethanol with sulfur trioxide. BES has been shown to be an effective catalyst in various organic reactions, including esterification, transesterification, and ring-opening reactions. Additionally, its strong acidity and unique properties make it a suitable electrolyte in electrochemical studies. The compound's ability to form stable salts with various organic and inorganic bases contributes to its utility in different scientific fields.'

2-bromoethanesulfonic acid: RN given refers to parent cpd; a methanogenic inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID33662
SCHEMBL ID24926
MeSH IDM0070829

Synonyms (21)

Synonym
2-bromoethanesulphonic acid
2-bromoethanesulfonic acid
AKOS006284717
unii-f7w8sd7w42
26978-65-4
einecs 248-150-8
f7w8sd7w42 ,
STL280265
FT-0611325
2-bromo-1-ethanesulfonic acid
SCHEMBL24926
OQFSYHWITGFERZ-UHFFFAOYSA-N
SY019880
mfcd08059352
DTXSID30181477
ethanesulfonic acid, 2-bromo-
9sb ,
2-bromanylethanesulfonic acid
2-bromoethanesulfonicacid
AS-31040
BBA97865

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" After 4 days of infusion however, and despite repeated pulse dosage of BES, methanogenesis adapted to BES and methane concentration in rumen gases reached 20%."( Attempts to induce reductive acetogenesis into a sheep rumen.
Demeyer, D; Fiedler, D; Immig, I; Mbanzamihigo, L; Van Nevel, C, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (15.49)18.7374
1990's9 (12.68)18.2507
2000's19 (26.76)29.6817
2010's31 (43.66)24.3611
2020's1 (1.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.04 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other71 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]